[Br:1][C:2]1[CH:11]=[C:10]2[C:5]([N:6]=[CH:7][C:8]([NH:12][NH:13][C:14]([CH:16]3[CH2:21][CH2:20][N:19](C(OC(C)(C)C)=O)[CH2:18][CH2:17]3)=O)=[N:9]2)=[CH:4][CH:3]=1>CC(O)=O>[Br:1][C:2]1[CH:11]=[C:10]2[C:5]([N:6]=[CH:7][C:8]3[N:9]2[C:14]([CH:16]2[CH2:21][CH2:20][NH:19][CH2:18][CH2:17]2)=[N:13][N:12]=3)=[CH:4][CH:3]=1A mixture of tert-butyl 4-(2-(7-bromoquinoxalin-2-yl)hydrazinecarbonyl)piperidine-1-carboxylate (900 mg, 2.0 mmol) in AcOH (10 mL) was refluxed overnight. Then the solvent was removed, and the residue was purified by ISCO (MeOH/H2O=20%-90%) to afford 8-bromo-1-(piperidin-4-yl)[1,2,4]triazolo[4,3-a]quinoxaline as a pale yellow solid (550 mg, yield 83.0%). MS (m/z): 332 (M+H)+.